<DOC>
	<DOC>NCT01628822</DOC>
	<brief_summary>The main objective of this protocol is to measure the improvement of the overall situation of patients with diffuse chronic pain or fibromyalgia to 12 weeks by non-drug treatment relaxation. Secondarily,is to evaluate the evolution of physical variables, psychological and social improvement of the quality of life. To evaluate the evolution of drug consumption</brief_summary>
	<brief_title>Efficacy Study of Relaxation to 12 Weeks Against Placebo in the Overall Care Chronic Pain in Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>Men or women over 18 years established diagnosis of fibromyalgia as defined by the American College of Rheumatology: widespread pain and eleven tender points at 18 sites listed (ACR, 1990) EVA â‰¥ 4 (on a scale of 10 cm) no change in treatment for 15 days, except for treatment "on demand" or "rescue" patient has given its written consent patient wishing to benefit from relaxation sessions people who can meet the selfassessment and heteroassessment people with a social security number any painful situation that cannot be distinguished from fibromyalgia pain by the patient patients untreated or treated for less than a month patient with psychosis or severe depression or severe anxiety or impulsivity characterized, at the discretion of the clinician. patients receiving benzodiazepines at the request patient with deafness patient after a body treatment using a relaxation method, relaxation therapy or hypnosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>Relaxation</keyword>
	<keyword>Improving the quality of life</keyword>
</DOC>